Cytokines and chemokines

Neuroimmune Pharmacology

Volumn , Issue , 2008, Pages 183-205

  Huang, Yunlong ^a   Erdmann, Nathan ^a   Hexum, Terry D ^a   Zheng, Jialin ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alzeimer's disease; Chemokine; Chemotaxis; Cytokine; Growth factor; HIV 1 associated dementia; Inflammation; Multiple sclerosis

Indexed keywords

EID: 80054909722     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-72573-4_15     Document Type: Chapter

References (244)

1. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol App Neurobiol 21:218-227.
2. Adorini L, Sinigaglia F (1997) Pathogenesis and immunotherapy of autoimmune diseases. Immunol Today 18:209-211.
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
4. Aktas O, Smorodchenko A, Brocke S, Infante-Duarte C, Topphoff US, Vogt J, Prozorovski T, Meier S, Osmanova V, Pohl E, Bechmann I, Nitsch R, Zipp F (2005) Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46:421-432.
5. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
6. Aloisi F (2001) Immune function of microglia. Glia 36:165-179.
7. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 149:2358-2366.
8. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti I (2001) Interleukin-10 prevents glutamatemediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104-3112.
9. Bachis A, Major EO, Mocchetti I (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J Neurosci 23:5715-5722.
10. Balashov KE, Rottman JB, Weiner HL, Hancock WW (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96:6873-6878.
11. Barak O, Goshen I, Ben-Hur T, Weidenfeld J, Taylor AN, Yirmiya R (2002) Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res 933:98-108.
12. Bazan J, Bacon K, Hardiman G, Wang W, Soo K, Rossi D, Greaves D, Zlotnik A, Schall T (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
13. Benveniste EN (1992) Inflammatory cytokines within the central nervous system: Sources, function and mechanisms of action. Am J Physiol 263(1 Pt 1):C1-C16.
14. Benveniste EN (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75:165-173.
15. Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657-700.
16. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF (1996) Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 156:3017-3023.
17. Bernard CC, de Rosbo NK (1991) Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol (Napoli) 13:171-178.
18. Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, Vicenzi E, Vago L, Lazzarin A, Poli G, Mantovani A (1996) Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis 174:1098-1101.
19. Berson JF, Doms RW (1998) Structure-function studies of the HIV-1 coreceptors. Semin Immunol 10:237-248.
20. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710.
21. Bitsch A, Kuhlmann T, Da Costa C, Bunkowski S, Polak T, Bruck W (2000) Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology. Glia 29:366-375.
22. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: Consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171.
23. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
24. Boutros T, Croze E, Yong VW (1997) Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J Neurochem 69:939-946.
25. Boven LA, Middel J, Portegies P, Verhoef J, Jansen GH, Nottet HS (1999) Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex. J Neuroimmunol 97:154-162.
26. Boven LA, Montagne L, Nottet HS, De Groot CJ (2000) Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol 122:257-263.
27. Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM (2000) Anti-inflammatory drugs protect against Alzheimer's disease at low doses. Arch Neurol 57:1586-1591.
28. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH (2005) Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48:16-42.
29. Chen W, Sulcove J, Frank I, Jaffer S, Ozdener H, Kolson DL (2002) Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: Apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J Virol 76:9407-9419.
30. Chung IY, Benveniste EN (1990) Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFNgamma, and IL-1 beta. J Immunol 144:2999-3007.
31. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G (1998) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. Aids 12:1327-1332.
32. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8 + T cells. Science 270:1811-1815.
33. Collman RG, Yi Y, Liu QH, Freedman BD (2000) Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: Implications for target cell tropism. J Leukoc Biol 68:318-323.
34. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95:3117-3121.
35. Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM, Vassileva G, Lira SA (2001) Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 21:3159-3165.
36. Correale J, Rojany M, Weiner LP (1997) Human CD8 + TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4 + T-cells by different mechanisms. J Neuroimmunol 80:47-64.
37. Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J (2002) Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J Neurovirol 8:585-598.
38. Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, Kalyuzhny A, Lee VM, Wolf B, Doms RW, Kolson DL (2000) Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons [In Process Citation]. Neuroscience 97:591-600.
39. Damaj BB, McColl SR, Mahana W, Crouch MF, Naccache PH (1996) Physical association of Gi2alpha with interleukin-8 receptors. J Biol Chem 271:12783-12789.
40. Danial NN, Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116:205-219.
41. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58:65-70.
42. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
43. Devi LA (2000) G-protein-coupled receptor dimers in the lime light. Trends Pharmacol Sci 21:324-326.
44. Dimitrov DS, Xiao X, Chabot DJ, Broder CC (1998) HIV coreceptors. J Membr Biol 166:75-90.
45. Dong Y, Benveniste EN (2001) Immune function of astrocytes. Glia 36:180-190.
46. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4 + cells is mediated by the chemokines receptor CC-CKR-5. Nature 381:667-673.
47. Ehrlich S, Infante-Duarte C, Seeger B, Zipp F (2003) Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine 24:244-253.
48. Eilbott DJ, Peress N, Burger H, LaNeve D, Orenstein J, Gendelman HE, Seidman R, Weiser B (1989) Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc Natl Acad Sci USA 86:3337-3341.
49. Esser R, Glienke W, von Briesen H, Rubsamen-Waigmann H, Andreesen R (1996) Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88:3474-3481.
50. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science 272:872-877.
51. Fiala M, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE (1998) Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 4:480-489.
52. Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, Khalili K, Rappaport J (2004) Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 164:2089-2099.
53. Frost EE, Nielsen JA, Le TQ, Armstrong RC (2003) PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 54:457-472.
54. Fuentes M, Durham S, Swerdel M, Letwin A, Barton D, Megill J, Bravo R, Lira L (1995) Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155:5769-5776.
55. Gabuzda D, Wang J (1999) Chemokine receptors and virus entry in the central nervous system. J Neurovirol 5:643-658.
56. Gabuzda D, Wang J (2000) Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 6(Suppl 1): S24-S32.
57. Gabuzda D, He J, Ohagen A, Vallat A (1998) Chemokine receptors in HIV-1 infection of the central nervous system. Immunol 10:203-213.
58. Gabuzda D, Wang J, Gorry P (2002) HIV-1-Associated Dementia. In: Chemokines and the Nervous System (Ransohoff RM, Suzuki K, Proudfoot AEI, Hickey WF, Harrison JK, eds), pp 345-360.Amsterdam: Elservier Science.
59. Gallo P, Sivieri S, Rinaldi L, Yan XB, Lolli F, De Rossi A, Tavolato B (1994) Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J Neurol Sci 126:49-53.
60. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE (1998) The alpha-chemokine, stromal cellderived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273:23169-23175.
61. Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T, Morrison RS (2004) HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 18:1141-1143.
62. Gelbard HA (1999) Neuroprotective strategies for HIV-1-associated neurologic disease. Ann N Y Acad Sci 890:312-313.
63. Gendelman HE, Folks DG (1999) Innate and acquired immunity in neurodegenerative disorders. J Leuk Biol 65:407-409.
64. Gendelman HE, Baca LM, Kubrak CA, Genis P, Burrous S, Friedman RM, Jacobs D, Meltzer MS (1992) Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN. J Immunol 148:422-429.
65. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997) The neuropathogenesis of the AIDS dementia complex. Aids 11:S35-45.
66. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Jr., Swindells S (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 178:1000-1007.
67. Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L, Gherardi G, Belardelli F (1994) Role of endogenous interferon-beta in the restriction of HIV replication in human monocyte/macrophages. J Leukoc Biol 56:358-361.
68. Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F (2003) Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 57:493-497.
69. Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinical neuropathologic correlation in HIV-associated dementia. Neurology 43:2230-2237.
70. Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, Auer J, Muller HW (2000) Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci 12:1857-1866.
71. Goda S, Imai T, Yoshie O, Yoneda O, Inoue H, Nagano Y, Okazaki T, Imai H, Bloom ET, Domae N, Umehara H (2000) CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and-independent mechanisms. J Immunol 164:4313-4320.
72. Godiska R, Chantry D, Dietsch GN, Gray PW (1995) Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167-176.
73. Goldgaber D, Harris H, Hla T, Maciag T, Donnelly R, Jacobsen J, Vitek M, Gajdusek D (1989) IL-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86:7606-7610.
74. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99:13795-13800.
75. Green DR (2003) The suicide in the thymus, a twisted trail. Nat Immunol 4:207-208.
76. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1311.
77. Griffin DE (1997) Cytokines in the brain during viral infection: Clues to HIV-associated dementia. J Clin Invest 100:2948-2951.
78. Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L, White C, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 86:7611-7615.
79. Griffin W, Sheng J, Roberts G, Mrak R (1995) Interleukin-1 expression in different plaque types in Alzheimer's diseases: Significance in plaque evolution. J Neuropathol Exp Neurol 54:276-281.
80. Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
81. Guo H, Jin YX, Ishikawa M, Huang YM, van der Meide PH, Link H, Xiao BG (1998) Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol 48:502-508.
82. Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40:140-155.
83. Harrison JK, Fong AM, Swain PA, Chen S, Yu YR, Salafranca MN, Greenleaf WB, Imai T, Patel DD (2001) Mutational analysis of the fractalkine chemokine domain: Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion. J Biol Chem 8:8.
84. Haskell CA, Cleary MD, Charo IF (2000) Unique role of the chemokine domain of fractalkine in cell capture kinetics of receptor dissociation correlate with cell adhesion. J Biol Chem 275:34183-34189.
85. Hausmann EH, Berman NE, Wang YY, Meara JB, Wood GW, Klein RM (1998) Selective chemokine mRNA expression following brain injury. Brain Res 788:49-59.
86. Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, Dolan MJ, Chougnet C, Lifson JD, Shearer GM (2005) TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105:2458-2464.
87. Hesselgesser J, Horuk R (1999) Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
88. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1alpha mediated by the chemokine receptor CXCR4. Curr Biol 8:595-598.
89. Hickey WF (1999) Leukocyte traffic in the central nervous system: The participants and their roles. Semin Immunol 11:125-137.
90. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
91. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2000) The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. J Neuroimmunol 107:161-166.
92. Hoover DM, Mizoue LS, Handel TM, Lubkowski J (2000) The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement. J Biol Chem 275:23187-23193.
93. Huang WX, Huang MP, Gomes MA, Hillert J (2000) Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology 55:928-934.
94. Huang Y, Erdmann N, Zhao J, Zheng J (2005a) The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia. Neurotox Res 8:135-148.
95. Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J (2005b) The role of TNF-related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2:113-122.
96. Huang Y, Erdmann N, Peng H, Herek S, Davis JS, Luo X, Ikezu T, Zheng J (2006) TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation. J Immunol 177:2304-2313.
97. Hulshof S, Montagne L, De Groot CJ, van der Valk P (2002) Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38:24-35.
98. Irani DN (1998) The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides. J Immunol 161:2746-2752.
99. Ishizuka K, Igata-Yi R, Kimura T, Hieshima K, Kukita T, Kin Y, Misumi Y, Yamamoto M, Nomiyama H, Miura R, Takamatsu J, Katsuragi S, Miyakawa T (1997) Expression and distribution of CC chemokine macrophage inflammatory protein-1 a/LD78 in the human brain. Neuroreport 8:1215-1218.
100. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, 3rd, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)s. Ann Neurol 39:285-294.
101. Jiang Y, Salafranca M, Adhikari S, Xia Y, Feng L, Sonntag M, deFiebre C, Pennel N, Streit W, Harrison J (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86:1-12.
102. Johnstone M, Gearing AJ, Miller KM (1999) A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93:182-193.
103. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
104. Kast RE (2002) Feedback between glial tumor necrosis factor-alpha and gp120 from HIV-infected cells helps maintain infection and destroy neurons. Neuroimmunomodulation 10:85-92.
105. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212-8216.
106. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
107. Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA (2007) HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ 14:296-305.
108. Kedzierska K, Crowe SM, Turville S, Cunningham AL (2003) The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 13:39-56.
109. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998) b-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44:831-835.
110. Kim CH, Broxmeyer HE (1999) Chemokines: Signal lamps for trafficking of T and B cells for development and effector function. J Leukocyte Biol 65:6-14.
111. Klein R, Williams K, Alvarez-Hernandez X, Westmoreland S, Force T, Lackner A, Luster A (1999) Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: Implications for the neuropathogenesis of AIDS. J Immunol 163:1636-1646.
112. Koenig S, Gendelman HE, Orenstein JM, Canto MCD, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
113. Korsching S (1993) The neurotrophic factor concept: A reexamination. J Neurosci 13:2739-2748.
114. Kuang Y, Wu Y, Jiang H, Wu D (1996) Selective G protein coupling by C-C chemokine receptors. J Biol Chem 271:3975-3978.
115. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202-2212.
116. Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM (2003) The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 307:122-134.
117. Langford D, Sanders VJ, Mallory M, Kaul M, Masliah E (2002) Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. J Neuroimmunol 127:115-126.
118. Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M, Jr., Lifson JD, Salkowitz JR, Rodriguez B, Blauvelt A, Hartley O (2004) Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306:485-487.
119. Lee S, Liu W, Dickson D, Brosnan C, Berman J (1993) Cytokine production by human fetal microglia and astrocytes: Differential induction by lipopolysaccharide and IL-1B. J Immunol 150:2659-2667.
120. Lewin GR, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
121. Li H, Newcombe J, Groome NP, Cuzner ML (1993) Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 19:214-223.
122. Lindberg C, Selenica ML, Westlind-Danielsson A, Schultzberg M (2005) Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci 27:1-12.
123. Little AR, O'Callagha JP (2001) Astrogliosis in the adult and developing CNS: Is there a role for proinflammatory cytokines? Neurotoxicology 22:607-618.
124. Logan A, Berry M (1993) Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 14:337-342.
125. Lotan M, Schwartz M (1994) Cross talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEB J 8:1026-1033.
126. Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, Powrie F, Greaves DR (2001) The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 158:855-866.
127. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
128. Lucchinetti CF, Brück W, and Lassmann H (2003) Neuroimmunologic Mechanisms in the Etiology of Multiple Sclerosis. In: Neuroinflammation: Mechanisms and Management (Wood PL, ed), pp 359-377. Totowa, N.J.: Humana Press.
129. Lue LF, Walker DG, Rogers J (2001) Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 22:945-956.
130. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703-5708.
131. Mason JL, Suzuki K, Chaplin DD, Matsushima GK (2001) Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046-7052.
132. Matusevicius D, Navikas V, Soderstrom M, Xiao BG, Haglund M, Fredrikson S, Link H (1996) Multiple sclerosis: The proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factoralpha are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol 66:115-123.
133. Matysiak M, Jurewicz A, Jaskolski D, Selmaj K (2002) TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain 125:2469-2480.
134. Matyszak MK (1998) Inflammation in the CNS: Balance between immunological privilege and immune responses. Prog Neurobiol 56:19-35.
135. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66:407-437.
136. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF (1998) MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study. J Neuroimmunol 86:20-29.
137. Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr., Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by betaamyloid protein and interferon-gamma. Nature 374:647-650.
138. Meda L, Baron P, Prat E, Scarpini E, Scarlato G, Cassatella MA, Rossi F (1999) Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with betaamyloid[ 25-35]. J Neuroimmunol 93:45-52.
139. Mellado M, Rodriguez-Frade JM, Manes S, Martinez AC (2001) Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19:397-421.
140. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE (1990) Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 8:169-194.
141. Meucci O, Miller R (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGFbeta1. J Neurosci 16:4080-4088.
142. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95:14500-14505.
143. Meucci O, Fatatis A, Simen AA, Miller RJ (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080.
144. Michael NL (2002) Host genetics and HIV-removing the mask. Nat Med 8:783-785.
145. Miller RJ, Meucci O (1999) AIDS and the brain: Is there a chemokine connection? Trends Neurosci 22:471-479.
146. Mizoue LS, Bazan JF, Johnson EC, Handel TM (1999) Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38:1402-1414.
147. Mizoue LS, Sullivan SK, King DS, Kledal TN, Schwartz TW, Bacon KB, Handel TM (2001) Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine. J Biol Chem 276:33906-33914.
148. Mizuno T, Kawanokuchi J, Numata K, Suzumura A (2003) Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979:65-70.
149. Monica J, Carson CSA, and Corinne P (2005) Multiple Sclerosis. In: Inflammatory Disorders of the Nervous System: Pathogenesis, Immunology, and Clinical Management (Alireza Minagar JSA, ed), pp 17-40.Totowa, N.J.: Humana Press.
150. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128.
151. Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116-122.
152. Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features I. Ann Neurol 19:517-524.
153. Neumann H, Misgeld T, Matsumuro K, Wekerle H (1998) Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci USA 95:5779-5784.
154. Offen D, Kaye JF, Bernard O, Merims D, Coire CI, Panet H, Melamed E, Ben-Nun A (2000) Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE). J Mol Neurosci 15:167-176.
155. Ohagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G, Gabuzda D (1999) Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope. J Virol 73:897-906.
156. Panitch HS, Hirsch RL, Haley AS, Johnson KP (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1:893-895.
157. Peng H, Huang Y, Rose J, Erichsen D, Herek S, Fujii N, Tamamura H, Zheng J (2004) Stromal cell-derived factor 1 mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res 76:35-50.
158. Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, Gendelman HE, Ghorpade A, Zheng J (2006) HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta. Glia 54:619-629.
159. Perno CF, Cooney DA, Currens MJ, Rocchi G, Johns DG, Broder S, Yarchoan R (1990) Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. AIDS Res Hum Retroviruses 6:1051-1055.
160. Perrella O, Carrievi P, Guarnaccia D, Soscia M (1992) Cerebrospinal fluid cytokines in AIDS dementia. J Neurol 239:387-388.
161. Perrella O, Carreiri PB, Perrella A, Sbreglia C, Gorga F, Guarnaccia D, Tarantino G (2001) Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): Possible relationship with cerebral viral load? Eur Cytokine Netw 12:51-55.
162. Perry VH (1998) A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90:113-121.
163. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929-979.
164. Petito CK, Vecchio D, Chen YT (1994) HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J Neuropathol Exp Neurol 53:86-94.
165. Poluektova L, Gorantla S, Faraci J, Birusingh K, Dou H, Gendelman HE (2004) Neuroregulatory events follow adaptive immunemediated elimination of HIV-1-infected macrophages: Studies in a murine model of viral encephalitis. J Immunol 172:7610-7617.
166. Prehn JH, Miller RJ (1996) Opposite effects of TGF-beta 1 on rapidly-and slowly-triggered excitotoxic injury. Neuropharmacology 35:249-256.
167. PRISMS STUDY GROUP (1998) In. Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS (2002) Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83:973-983.
168. Ransohoff RM, Hamilton TA, Tani M (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592-600.
169. Renauld JC (2003) Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators. Nat Rev Immunol 3:667-676.
170. Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T (1995) TNFalpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 154:944-953.
171. Ringheim GE, Conant K (2004) Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections). J Neuroimmunol 147:43-49.
172. Rizzardi GP, Lazzarin A, Pantaleo G (2002) Potential role of immune modulation in the effective long-term control of HIV-1 infection. J Biol Regul Homeost Agents 16:83-90.
173. Rohowsky-Kochan C, Troiano R, Cook SD (1989) MHC-restricted autoantigen-reactive T cell clones in multiple sclerosis. J Immunogenet 16:437-444.
174. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242.
175. Rostasy K, Egles C, Chauhan A, Kneissl M, Bahrani P, Yiannoutsos C, Hunter DD, Nath A, Hedreen JC, Navia BA (2003) SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: An in vivo and in vitro study. J Neuropathol Exp Neurol 62:617-626.
176. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ (1997) Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 151:1341-1351.
177. Ryan LA, Cotter RL, Zink WE, Gendelman HE, Zheng J (2002) Macrophages, chemokines and neuronal injury in HIV-1 associated dementia. Cell Mol Biol 48:125-138.
178. Ryan LA, Peng H, Erichsen DA, Huang Y, Persidsky Y, Zhou Y, Gendelman HE, Zheng J (2004) TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: Links to HIV-1 associated dementia. J Neuroimmunol 148:127-139.
179. Saha RN, Pahan K (2003) Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem 86:1057-1071.
180. Sanders VJ, Mehta AP, White MG, Achim CL (1998) A murine model of HIV encephalitis: Xenotransplantation of HIV-infected human neuroglia into SCID mouse brain. Neuropathol Appl Neurobiol 24:461-467.
181. Sattentau QJ, Weiss RA (1988) The CD4 antigen: Physiological ligand and HIV receptor. Cell 52:631-633.
182. Scorziello A, Florio T, Bajetto A, Thellung S, Schettini G (1997) TGF-beta1 prevents gp120-induced impairment of Ca2 + homeostasis and rescues cortical neurons from apoptotic death. J Neurosci Res 49:600-607.
183. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3:75-80.
184. Shaheen F, Collman RG (2004) Co-receptor antagonists as HIV-1 entry inhibitors. Curr Opin Infect Dis 17:7-16.
185. Shapshak P, Duncan R, Minagar A, Rodriguez de la Vega P, Stewart RV, Goodkin K (2004) Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 9:1073-1081.
186. Sheng J, Griffin W, Royston M, Mrak R (1998) Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: Implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol 24:278-283.
187. Shi B, Rainha J, Lorenzo A, Busciglio J, Gabuzda D (1998) Neuronal apoptosis induced by HIV-1 tat protein and TNF-a: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 4:281-290.
188. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN (1998) Expression of monocyte chemoattractant protein-1 and other betachemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238-249.
189. Sippy BD, Hofman FM, Wallach D, Hinton DR (1995) Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 10:511-521.
190. Song L, Pachter JS (2004) Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res 67:78-89.
191. Soontornniyomkij V, Wang G, Pittman CA, Wiley CA, Achim CL (1998) Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neuropathol Appl Neurobiol 24:453-460.
192. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
193. Srinivasan D, Yen JH, Joseph DJ, Friedman W (2004) Cell typespecific interleukin-1beta signaling in the CNS. J Neurosci 24:6482-6488.
194. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells? Brain 125:75-85.
195. Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, Lubetzki C (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: A novel role for CNTF and CNTF-related molecules. J Neurosci 22:9221-9227.
196. Stewart W, Kawas C, Corrada M, Metter E (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
197. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
198. Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, Nagasawa T, Hollt V, Schulz S (2003) CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 23:5123-5130.
199. Tang J, Kaslow RA (2003) The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy. Aids 17(Suppl 4):S51-S60.
200. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-1398.
201. Tarkowski E, Blenow K, Wallin A, Tarkowski A (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent in Alzheimer disease and vascular dementia. Clin Immunol 19:223-230.
202. Tong N, Perry SW, Zhang Q, James HJ, Guo H, Brooks A, Bal H, Kinnear SA, Fine S, Epstein LG, Dairaghi D, Schall TJ, Gendelman HE, Dewhurst S, Sharer LR, Gelbard HA (2000) Neuronal fractalkine expression in HIV-1 encephalitis: Roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164:1333-1339.
203. Tran PB, Miller RJ (2003) Chemokine receptors: Signposts to brain development and disease. Nat Rev Neurosci 4:444-455.
204. Trapp BD, Bo L, Mork S, Chang A (1999) Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49-56.
205. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992) Cytokine expression in the brain during acquired immune deficiency syndrome. Ann Neurol 31:349-360.
206. Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bernardini R, Memo M (2004) TRAIL is expressed in the brain cells of Alzheimer's disease patients. Neuroreport 15:579-581.
207. Vallat A-V, Girolami UD, He J, Mhashikar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Path 152:167-178.
208. Van der Meer P, Ulrich AM, Gonzalez-Scarano F, Lavi E (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: Potential mechanisms for HIV dementia. Exp Mol Pathol 69:192-201.
209. Van der Voorn P, Tekstra J, Beelen RH, Tensen CP, van der Valk P, De Groot CJ (1999) Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol 154:45-51.
210. Van der Wal EA, Gomez-Pinilla F, Cotman CW (1993) Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69-72.
211. Van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, Rourke SB, Holden J, McArthur JC, Gill MJ, Power C (2004) Human immunodeficiency virus type 1 Nef protein mediates neural cell death: A neurotoxic role for IP-10. Virology 329:302-318.
212. Vergote D, Butler GS, Ooms M, Cox JH, Silva C, Hollenberg MD, Jhamandas JH, Overall CM, Power C (2006) Proteolytic processing of SDF-1{alpha} reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Natl Acad Sci USA 103:19182-19187.
213. Vilcek J (2003) The cytokines: An overview. In: The Cytokine Handbook, 4th Edition (Angus W Thomson MTL, ed), pp 1-18. San Diego: Academic Press.
214. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP (2000) Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 191:1799-1806.
215. Wajgt A, Gorny M (1983) CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol Scand 68:337-343.
216. Walz A, Peveri P, Aschauer H, Baggiolini M (1987) Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149:755-761.
217. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933.
218. Wesselingh SL, Power C, Glass JD (1993) Intracerebral cytokine messenger RNA expression in acquired immunedeficiency syndrome dementia. Ann Neurol 33:576-582.
219. Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG (1998) Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 152:659-665.
220. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.
221. Williams K, Schwartz A, Corey S, Orandle M, Kennedy W, Thompson B, Alvarez X, Brown C, Gartner S, Lackner A (2002) Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am J Pathol 161:575-585.
222. Wingerchuk DM, Weinshenker BG (2000) Multiple sclerosis: Epidemiology, genetics, classification, natural history, and clinical outcome measures. Neuroimaging Clin N Am 10:611-624.
223. Wosik K, Antel J, Kuhlmann T, Bruck W, Massie B, Nalbantoglu J (2003) Oligodendrocyte injury in multiple sclerosis: A role for p53. J Neurochem 85:635-644.
224. Wright JL, Merchant RE (1992) Histopathological effects of intracerebral injections of human recombinant tumor necrosis factoralpha in the rat. Acta Neuropathol (Berl) 85:93-100.
225. Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman JW (2000) Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 6(Suppl 1): S82-S85.
226. Xia M, Hyman BT (1999) Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 5:32-41.
227. Xia M, Hyman BT (2002) GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-A role in Alzheimer's disease? J Neuroimmunol 122:55-64.
228. Xia M, Qin S, McNamara M, Mackay C, Hyman B (1997) Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150:1267-1274.
229. Xia M, Qin S, Wu L, Mackay C, Hyman B (1998) Immunohistochemical study of the b-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 153:31-37.
230. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT (2000) Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: In vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108:227-235.
231. Xiao BG, Link H (1998) Immune regulation within the central nervous system. J Neurol Sci 157:1-12.
232. Yong VW, Chabot S, Stuve O, Williams G (1998) Interferon beta in the treatment of multiple sclerosis: Mechanisms of action. Neurology 51:682-689.
233. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ (1987) Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL 1). J Immunol 139:788-793.
234. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064-1071.
235. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD (1998) In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 72:5035-5045.
236. Zhao ML, Kim MO, Morgello S, Lee SC (2001) Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 115:182-191.
237. Zheng J, Ghorpade A, Niemann D, Cotter RL, Thylin MR, Epstein L, Swartz JM, Shepard RB, Liu X, Nukuna A (1999a) Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia. J Virol 73:8256-8267.
238. Zheng J, Thylin M, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng Y, Gelbard H (1999b) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98:185-200.
239. Zheng J, Bauer M, Cotter RL, Ryan LA, Lopez A, Williams C, Ghorpade A, Gendelman HE (2000a) Fractalkine Mediated Macrophage Activation by Neuronal Injury: Relevance for HIV-1 Associated Dementia. In: 30th Annual Meeting of Society for Neuroscience. New Orleans: Society for Neuroscience.
240. Zheng J, Niemann D, Bauer M, Leisman GB, Cotter RL, Ryan LA, Lopez A, Williams C, Ghorpade A, Gendelman HE (2000b) a-Chemokines and Their Receptors in the Neuronal Signaling: Relevance for HIV-1-Associated Dementia. In: 7th Conference on Retroviruses and Opportunistic Infections. San Francisco: Foundation for Retrovirology and Human Health.
241. Zheng J, Niemann D, Bauer M, Williams C, Lopez A, Erichsen D, Ryan LA, Cotter RL, Ghorpade A, Swindells S (2001) HIV-1 Glia Interactions in Interleukin-8 and Growth-Related Oncogene a Secretion, Neuronal Signaling and Demise: Relevance for HIV-1-Associated Dementia. In: 8th Conference on Retroviruses and Opportunistic Infections, p 227. Chicago: Foundation for retrovirology and human health.
242. Zhou N, Fang J, Mukhtar M, Acheampong E, Pomerantz RJ (2004) Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene Ther 11:1703-1712.
243. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001) Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 184:1015-1021.
244. Zujovic V, Benavides J, Vige X, Carter C, Taupin V (2000) Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation [In Process Citation]. Glia 29:305-315.